Taspoglutide
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Roche · Phase 3 · Completed · Enrollment 305
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| placebo | T2D only | n/r | 4 | n/r | n/r |
| taspoglutide | T2D only | n/r | 4 | n/r | n/r |